TY  - JOUR
T1  - Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth
JF  - Cancer Immunology, Immunotherapy
DO  - 10.1007/s00262-017-2067-y
AU  - Belyaev N.N., 
AU  - Abdolla N., 
AU  - Perfilyeva Y.V., 
AU  - Ostapchuk Y.O., 
AU  - Kali A., 
AU  - Tleulieva R., 
AU  - Krasnoshtanov V.K., 
Y1  - 2023-07-12
UR  - https://pasteur.elpub.ru/publication/3608
N2  -